TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34088700

Group type: EXPERIMENTAL
Intervention: Genetic liability to T2D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically instrumented higher insulin resistance (IR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic liability to HF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasting insulin, glucose, or glycated hemoglobin
Number of subjects: 0
Study: 32297772

Group type: EXPERIMENTAL
Intervention: Type D personality
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-Type D personality
Number of subjects: 70
Study: 35680613

Group type: EXPERIMENTAL
Intervention: GI Genius™-assisted colonoscopy
Number of subjects: 1828

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1828
Study: 32125906

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (TAF)
Number of subjects: 0
Study: 35008045

Group type: EXPERIMENTAL
Intervention: mHealth with no home visits
Number of subjects: 2626

Group type: EXPERIMENTAL
Intervention: mHealth with two home visits
Number of subjects: 2626

Group type: COMPARATOR
Intervention: Standard message arm
Number of subjects: 2626
Study: 32204742

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: General Psychiatric Management (GPM)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Model-predicted optimal treatment
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Model-predicted optimal treatment (top 60% prediction)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Model-predicted optimal treatment (conservative check)
Number of subjects: 156
Study: 34028575

Group type: EXPERIMENTAL
Intervention: Preoperative telehealth call (3 ± 2 days before surgery)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Preoperative telehealth call
Number of subjects: 132

Group type: COMPARATOR
Intervention: Usual preoperative counseling alone
Number of subjects: 132
Study: 34932756

Group type: EXPERIMENTAL
Intervention: Conventional TENS Group (continuous stimulation at 100Hz for 100µs with sensory intensity)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Burst TENS Group (stimulation at 100Hz modulated at 2Hz for 100µs with motor-level intensity)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo Group (sham electrical stimulation)
Number of subjects: 105
Study: 626733905

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid combined with tiotropium bromide
Number of subjects: 86

Group type: COMPARATOR
Intervention: Inhaled glucocorticoid
Number of subjects: 86
Study: 35298440

Group type: EXPERIMENTAL
Intervention: Baseline sRAGE
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Plasma sRAGE in the highest quartile
Number of subjects: 277
Study: 33423837

Group type: EXPERIMENTAL
Intervention: Educational videos about vaccines and small pharmacy-based financial incentives for vaccine receipt
Number of subjects: 277
Study: 32738365

Group type: EXPERIMENTAL
Intervention: Acupressure therapy in combination with pharmacological treatment (n = 106)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Pharmacological treatment only (Control group, n = 106)
Number of subjects: 212
Study: 36217659

Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioral therapy (9 sessions over 8 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine treatment with medication and vestibular rehabilitation (control group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioral therapy
Number of subjects: 86
Study: 34398958

Group type: EXPERIMENTAL
Intervention: Empiric TB therapy
Number of subjects: 850

Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 850
Study: 32096209

Group type: EXPERIMENTAL
Intervention: 200 mg of red wine oligomeric procyanidins (OPCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 100
Study: 35361049

Group type: EXPERIMENTAL
Intervention: Stress condition (fake negative feedback and ostracism)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No-stress condition
Number of subjects: 70
Study: 32992347

Group type: EXPERIMENTAL
Intervention: Novel scoring system based on endoscopic appearance (including tumor size, shape, and mucosal surface)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Novel scoring system based on endoscopic appearance
Number of subjects: 309
Study: 32403902

Group type: EXPERIMENTAL
Intervention: Procaterol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 35220442

Group type: EXPERIMENTAL
Intervention: + UVB WGO
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no WGO)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: – UVB WGO
Number of subjects: 46
Study: 32659699

Group type: EXPERIMENTAL
Intervention: 12 weeks web‐based intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Routine face to face occupational therapy intervention (Control)
Number of subjects: 91
Study: 36424332

Group type: EXPERIMENTAL
Intervention: Crush mobile application
Number of subjects: 1210

Group type: COMPARATOR
Intervention: Control group (wellness app)
Number of subjects: 1210
Study: 34697783

Group type: EXPERIMENTAL
Intervention: Ulmus macrocarpa Hance extract (UME) 500 mg/day for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33151988

Group type: EXPERIMENTAL
Intervention: Indigo naturalis (IN) 500 mg, 5 capsules twice a day for 2 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33492301

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg/d for 12 weeks
Number of subjects: 60
Study: 32086358

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention in primary healthcare (PHC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual follow-up
Number of subjects: 200
Study: 34314941

Group type: EXPERIMENTAL
Intervention: Synchronous online training with feedback devices (TF)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Face-to-face training with feedback devices (FF)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Synchronous online training without feedback devices (TN)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Face-to-face training without feedback devices (FN)
Number of subjects: 118
Study: 33317460

Group type: EXPERIMENTAL
Intervention: Dyclonine hydrochloride mucilage (Group N‐AIC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oropharyngeal tetracaine spray (Group S‐AIC)
Number of subjects: 60
Study: 34407970

Group type: EXPERIMENTAL
Intervention: Nivolumab (N) 240 mg every 2 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab (N + I) 240 mg every 2 weeks + 1 mg/kg every 6 weeks
Number of subjects: 36
Study: 33547848

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 940

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 940
Study: 32622900

Group type: EXPERIMENTAL
Intervention: Cancer treatments with statistically significant increase in overall survival
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Cancer treatments with overall survival as primary outcome
Number of subjects: 234
Study: 34519703

Group type: EXPERIMENTAL
Intervention: Lateral Crural Steal (LCS) and Tongue in Groove (TING) techniques
Number of subjects: 65

Group type: COMPARATOR
Intervention: Cartilage grafts (Control Group)
Number of subjects: 65
Study: 33231029

Group type: EXPERIMENTAL
Intervention: GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard PTA treatment
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 35260415

Group type: EXPERIMENTAL
Intervention: Tall man lettering (TML) coded labels
Number of subjects: 30
Study: 33439282

Group type: COMPARATOR
Intervention: Episiotomy
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Spontaneous perineal tears
Number of subjects: 525

Group type: COMPARATOR
Intervention: Episiotomy (in vacuum-assisted deliveries)
Number of subjects: 525
Study: 35909163

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C (TTM33)
Number of subjects: 1850
Study: 32845446

Group type: EXPERIMENTAL
Intervention: Education plus individualized feedback via an online dashboard
Number of subjects: 45

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 45
Study: 36424532

Group type: EXPERIMENTAL
Intervention: Normal walking (120 steps/min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Paced walking (125 steps/min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Music-synchronised walking (120-128 steps/min)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 78
Study: 33483110

Group type: EXPERIMENTAL
Intervention: Hypoventilation therapy (TX, n = 20)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist control (WL, n = 17)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy controls (HC, n = 29)
Number of subjects: 37
Study: 32554385

Group type: EXPERIMENTAL
Intervention: In-person NDPP with SMS4PreDM (n=236)
Number of subjects: 488

Group type: COMPARATOR
Intervention: In-person NDPP alone (n=252)
Number of subjects: 488
Study: 36155241

Group type: EXPERIMENTAL
Intervention: Biportal endoscopic discectomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Microscopic discectomy
Number of subjects: 64
Study: 32902676

Group type: EXPERIMENTAL
Intervention: 1-day ejaculatory abstinence period
Number of subjects: 120

Group type: COMPARATOR
Intervention: 3-day ejaculatory abstinence period
Number of subjects: 120
Study: 32102056

Group type: EXPERIMENTAL
Intervention: HA‐EUH (Heat Acclimation with Euhydration)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HA‐DEH (Heat Acclimation with Dehydration)
Number of subjects: 8
Study: 35863814

Group type: EXPERIMENTAL
Intervention: CPVI plus low-voltage area (LVA) modification
Number of subjects: 300

Group type: COMPARATOR
Intervention: CPVI alone
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: CPVI plus LVA modification
Number of subjects: 300
Study: 34545117

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics administered by paramedics
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Paramedics trained in sepsis screening and blood culture collection
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Follow-up at 90 days
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Recruitment and delivery of intervention
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 114
Study: 36208220

Group type: EXPERIMENTAL
Intervention: B-SWELL intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wellness (WE) intervention
Number of subjects: 48
Study: 34488061

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (intravenous 0.4 ?g/kg/h immediately after anesthesia induction and 0.1 ?g/kg/h after extubation, maintained until 24 h)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 102
Study: 32917645

Group type: EXPERIMENTAL
Intervention: Vitamin D (1,000 IU/day)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Calcium (1,200 mg/day)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Vitamin D (1,000 IU/day) in patients with DBP2 isoform
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Calcium (1,200 mg/day) in patients with DBP2 isoform
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D in patients with DBP2 isoform
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 36219325

Group type: EXPERIMENTAL
Intervention: Bandebereho intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34129236

Group type: EXPERIMENTAL
Intervention: Dichlorphenamide (DCP) 50 mg twice daily
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 32434574

Group type: EXPERIMENTAL
Intervention: Individualized cardiometabolic disease risk score communicated through an online risk score (ORS)
Number of subjects: 7547

Group type: COMPARATOR
Intervention: Control group who answered questions about CMD risk without receiving an individualized CMD risk score
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: Individualized CMD risk score
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: Family history for diabetes type 2
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: Family history for cardiovascular disease
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: BMI ≥25
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: High waist circumference
Number of subjects: 7547

Group type: EXPERIMENTAL
Intervention: Physical inactivity
Number of subjects: 7547
Study: 32996796

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33065228

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Concurrent training with resistive equipment (CTRE)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Concurrent training with multiple sets (CTMS)
Number of subjects: 57
Study: 34583271

Group type: EXPERIMENTAL
Intervention: Pictorial warning labels (PWLs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Text-only label (control)
Number of subjects: 0
Study: 33556123

Group type: EXPERIMENTAL
Intervention: 14-variable gradient boosting model
Number of subjects: 20985

Group type: EXPERIMENTAL
Intervention: SafeNET score calculated by bedside nurse
Number of subjects: 20985
Study: 36288585

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% and dexmedetomidine 1 mcg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (N/S) 0.9%
Number of subjects: 60
Study: 32400704

Group type: EXPERIMENTAL
Intervention: Sparse spectrum with uniform wave vectors (SU) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sparse spectrum (SS) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subharmonics complemented discrete Fourier transform (DFT) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized DFT technique
Number of subjects: 0
Study: 35620382

Group type: EXPERIMENTAL
Intervention: Guidewire-assisted reduction technology combined with upright posture (experimental group)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Guidewire-assisted reduction technology (control group)
Number of subjects: 99
Study: 34797324

Group type: EXPERIMENTAL
Intervention: N-butylphthalide (NBP) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: N-butylphthalide placebo
Number of subjects: 0
Study: 32571397

Group type: EXPERIMENTAL
Intervention: Resin-based bloc endocrown
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ceramic endocrown
Number of subjects: 156
Study: 35621342

Group type: EXPERIMENTAL
Intervention: Integrating intimate partner violence advocates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhancing medical training
Number of subjects: 0
Study: 32066898

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Non-treatment visits
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Injection visits
Number of subjects: 1190
Study: 34239102

Group type: EXPERIMENTAL
Intervention: Mass spectrometry-based metabolomics approaches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guidelines for sample preparation, replication and randomization, quantification, recovery and recombination, ion suppression and peak misidentification
Number of subjects: 0
Study: 32429465

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab (CT + B)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Chemotherapy (CT) alone
Number of subjects: 141
Study: 32267481

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 144

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 144
Study: 35615931

Group type: EXPERIMENTAL
Intervention: Imatinib cessation
Number of subjects: 199
Study: 32517393

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-bupivacaine (DB) group (n = 40) - 30 mL bupivacaine 0.25% plus 1 mu g/kg dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bupivacaine (B) group (n = 40) - 30 mL bupivacaine 0.25% only
Number of subjects: 80
Study: 33211886

Group type: COMPARATOR
Intervention: Sodium bicarbonate (3 g/day)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Citrate mixture (7 g/day)
Number of subjects: 200
Study: 34231231

Group type: EXPERIMENTAL
Intervention: Slow, deep breathing (SDB) with inspiratory threshold load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow, deep breathing (SDB) without inspiratory threshold load
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled breathing (CB) at a normal frequency (0.23 Hz)
Number of subjects: 0
Study: 36249246

Group type: EXPERIMENTAL
Intervention: Weekly SMS intervention for improving feeding practices
Number of subjects: 202
Study: 33919722

Group type: EXPERIMENTAL
Intervention: 25 mL extra-virgin olive oil supplement
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 3
Study: 36088325

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (Opalescence Boost 40%)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide (Opalescence PF 16%)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tea and coffee (Staining agents)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Red wine (Staining agent)
Number of subjects: 80
Study: 33878164

Group type: EXPERIMENTAL
Intervention: Evolved protein-protein interaction (PPI) networks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random deletion of proteins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random deletion of proteins restricted to those disrupted in LTEE
Number of subjects: 0
Study: 35933278

Group type: EXPERIMENTAL
Intervention: 1-week PrEP with human diploid cell culture rabies vaccine (HDCV) IM (Group 1)
Number of subjects: 570

Group type: COMPARATOR
Intervention: 3-week PrEP with human diploid cell culture rabies vaccine (HDCV) IM (Group 2)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 1-week PrEP with HDCV ID (Group 3)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 1-week PrEP with Vero cell rabies vaccine (PVRV) IM (Group 4)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: 1-week PrEP with Vero cell rabies vaccine (PVRV) ID (Group 5)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: All groups after simulated PEP
Number of subjects: 570
Study: 32471382

Group type: EXPERIMENTAL
Intervention: Modified FOLFIRINOX for 3 months
Number of subjects: 574

Group type: COMPARATOR
Intervention: RCT (Cap50 intensified-modulated radiotherapy)
Number of subjects: 574
Study: 35669363

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Number of subjects: 422

Group type: COMPARATOR
Intervention: Oral hypoglycemic drugs or diet control, appropriate exercise
Number of subjects: 422
Study: 34100843

Group type: EXPERIMENTAL
Intervention: Pharmacological anticoagulation
Number of subjects: 1776

Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 1776
Study: 32620184

Group type: EXPERIMENTAL
Intervention: Nighttime sleep complaints (sleep quality and refreshment)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Daytime dysfunction (fatigue, sleepiness, and difficulty concentrating)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 332
Study: 35963558

Group type: EXPERIMENTAL
Intervention: Combined treatment (d-methylphenidate + guanfacine)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: D-methylphenidate
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 172
Study: 33714191

Group type: EXPERIMENTAL
Intervention: Exercise training (combined resistance and aerobic training, 40-60 min, 4 days/week for 12 weeks)
Number of subjects: 35
Study: 32820324

Group type: EXPERIMENTAL
Intervention: RFA using oesophageal probes (SensiTherm™) in OPERA+ group
Number of subjects: 180

Group type: COMPARATOR
Intervention: RFA using fixed energy levels of 25 W in OPERA- group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study: 35368384

Group type: EXPERIMENTAL
Intervention: Ruxolitinib 5 mg twice per day
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 432
Study: 33019874

Group type: EXPERIMENTAL
Intervention: PEMs from Cancer Care Ontario (CCO)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PEMs from BC Cancer (BCC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Antibody-based therapies (PEMs from BCC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Small molecule-based therapies (PEMs from BCC)
Number of subjects: 80
Study: 36181554

Group type: EXPERIMENTAL
Intervention: Digital therapeutic app delivering cognitive behavioral therapy (BT‐001)
Number of subjects: 669

Group type: COMPARATOR
Intervention: Control app
Number of subjects: 669
Study: 33549004

Group type: EXPERIMENTAL
Intervention: Palliative care education and training program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standardized training only (Control)
Number of subjects: 72
Study: 32866625

Group type: EXPERIMENTAL
Intervention: Paclitaxel and Trastuzumab (TH)
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Anthracycline/Cyclophosphamide/Taxane/Trastuzumab (ACTH) or Taxane/Carboplatin/Trastuzumab (TCH)
Number of subjects: 1770
Study: 34509310

Group type: EXPERIMENTAL
Intervention: Polyamide sutures
Number of subjects: 112

Group type: COMPARATOR
Intervention: Chromic gut sutures
Number of subjects: 112
Study: 32192020

Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) app
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lifestyle education program delivered via smartphone (SPCTL)
Number of subjects: 30
Study: 35048657

Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Hot snare polypectomy (HSP)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 112